Our integrated case management programs reduce death and severe disease through prompt and effective diagnosis and treatment where and when people need it.
Our integrated case management (ICM) programs improve access to effective treatment, enhance quality of care and increase informed demand among caregivers to seek prompt and effective treatment from trained providers. Global efforts including ICM programs are on course to reduce child mortality by two thirds by 2015, compared to 1990 levels.
To increase access to proper diagnosis and quality treatment, our ICM programs work through pharmacy networks, franchised and non-franchised private clinics and community health workers (CHWs) to reach caregivers of children under five with the quality services and commodities they need. Our ICM programs focus on treatment of pneumonia, diarrhea, malaria and severe acute malnutrition.
In most of the countries where we operate, bacterial pneumonia remains one of leading causes of death for children. Our programs focus on:
- Making antibiotic treatment accessible and affordable, especially to facilities utilized by low income families.
- Helping private and community-based providers better identify pneumonia and use a full course of antibiotics.
- Promoting early care seeking behaviors from the parents and caregivers of small children and babies.
In many endemic countries, fever has always been associated with malaria. However, recent successes in malaria control have reduced the malaria burden – meaning that not every fever is malaria. Continuing to treat each fever case as malaria can not only lead to wastage of drugs, but also to under-treatment of other potentially serious febrile illnesses.
We support global efforts to increase effective access to malaria diagnosis through the use of Rapid Diagnostic Tests (RDT) and treatment with Artemisinin-based combination therapies (ACT) via the most appropriate channels for the caregivers of young children, primarily through the private sector and community-based channels. These efforts gain support from innovative communications approaches that emphasize the need for prompt diagnosis and treatment of children with fever.
In 2013, PSI distributed 14.1 million packages of the most effective malaria treatment across 12 countries. We also distribute and track the use of RDTs in the private sector in five countries across Africa and Asia. We now focus more closely on integrated case management by using these same channels to provide parasitological diagnosis for malaria and manage cases of non-severe febrile illness.
Diarrheal disease continues to be one of the leading causes of child morbidity and mortality globally, with more than 2.5 billion cases every year and contributing to 14 percent of deaths among children under five years old. Many of these cases can be prevented and effectively treated with oral rehydration solution (ORS) and zinc.
We promote and distribute diarrhea treatment kits, which are pre-packaged combinations of two ORS sachets and ten dispersible zinc tablets, to provide caregivers an easy to use treatment that reduces the duration and severity of diarrhea episodes.
Each year, severe acute malnutrition (SAM) affects more than 20 million children under five years old, with more than one million deaths. Current SAM interventions are mainly targeted in emergency contexts where the need is heightened. Meanwhile, children under five years old living in non-emergency contexts typically go unnoticed by governments and donors alike.
We are exploring how to integrate the treatment of SAM using a community-based management approach. Given our vast network of community health workers and social franchises, outreach and care can be provided on an outpatient basis through early identification of children with acute malnutrition.